Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps
Clinical Gastroenterology and Hepatology · 2024
DOI: 10.1016/j.cgh.2024.01.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024. Verfasst von Manuel Zorzi und 26 weiteren Autor:innen. Beteiligte Einrichtung: Veneto Tumor Registry, Azienda Zero, Padova, Italy. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Colonoscopy, Colonic Polyps. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Post-fecal immunochemical test (FIT) colonoscopy represents a setting with an enriched prevalence of advanced adenomas. Due to an expected higher risk of colorectal cancer (CRC), postpolypectomy surveillance is recommended, generating a substantially increased load on endoscopy services. The aim of our study was to investigate postpolypectomy CRC risk in a screening population of FIT+ subjects after resection of low-risk adenomas (LRAs) or high-risk adenomas (HRAs). METHODS: We retrieved data from a cohort of patients undergoing postpolypectomy surveillance within a FIT-based CRC screening program in Italy between 2002 and 2017 and followed-up to December 2021. Main outcomes were postpolypectomy CRC incidence and mortality risks according to type of adenoma (LRA/HRA) removed at colonoscopy as well as morphology, size, dysplasia, and location of the index lesion. We adopted as comparators FIT+/colonoscopy-negative and FIT- patients. The absolute risk was calculated as the number of incident CRCs per 100,000 person-years of follow-up. We used Cox multivariable regression models to identify associations between CRC risks and patient- and polyp-related variables. RESULTS: Overall, we included 87,248 post-FIT+ colonoscopies (133 endoscopists). Of these, 42,899 (49.2%) were negative, 21,650 (24.8%) had an LRA, and 22,709 (26.0%) an HRA. After a median follow-up of 7.25 years, a total of 635 CRCs were observed. For patients with LRAs, CRC incidence (hazard ratio [HR], 1.18; 95% confidence interval [CI], 0.92-1.53) was not increased compared with the FIT+/colonoscopy-negative group, while for HRAs a significant increase in CRC incidence (HR, 1.53; 95% CI, 1.14-2.04) was found. The presence of 1 or more risk factors among proximal location, nonpedunculated morphology, and high-grade dysplasia explained most of this excess CRC risk in the HRA group (HR, 1.85; 95% CI, 1.36-2.52). Patients with only distal pedunculated polyps without high-grade dysplasia, representing 39.2% of HRA, did not have increased risk compared with the FIT- group (HR, 0.87; 95% CI, 0.59-1.28). CONCLUSIONS: CRC incidence is significantly higher in patients with HRAs diagnosed at colonoscopy. However, such excess risk does not appear to apply to patients with only distal pedunculated polyps without high-grade dysplasia, an observation that could potentially reduce the burden of surveillance in FIT programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Veneto Tumor Registry, Azienda Zero, Padova, Italy.
- Department of Anatomical, Histological, Forensic Medicine and Orthopedics Sciences, Sapienza University of Rome, Rome, Italy; Gastroenterology and Digestive Endoscopy Unit, Ospedale dei Castelli Hospital, Ariccia, Italy…
- Gastroenterology and Digestive Endoscopy Unit, San Martino Hospital, ULSS 1 Dolomiti, Belluno, Italy.
- Gastroenterology and Digestive Endoscopy Unit, Santa Maria del Prato Hospital, ULSS 1 Dolomiti, Feltre, Italy.
- Gastroenterology and Digestive Endoscopy Unit, Azienda ULSS 2 Marca Trevigiana, Treviso, Italy.
- Gastroenterology and Digestive Endoscopy Unit, Azienda ULSS 2 Marca Trevigiana, Conegliano, Italy.
Zitieren
APA
Zorzi, M., Battagello, J., Amidei, C. B., Antonelli, G., Germanà, B., Valiante, F., Benvenuti, S., Tringali, A., Bortoluzzi, F., Cervellin, E., Giacomin, D., Meggiato, T., Rizzotto, E. R., Fregonese, D., Dinca, M., Baldassarre, G., Scalon, P., Pantalena, M., Milan, L., …, & Hassan, C. (2024). Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2024.01.027
Vancouver
Zorzi M, Battagello J, Amidei CB, Antonelli G, Germanà B, Valiante F, et al. Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps. Clinical Gastroenterology and Hepatology. 2024. doi:10.1016/j.cgh.2024.01.027
BibTeX
@article{Zorzi2024,
author = {Zorzi, Manuel and Battagello, Jessica and Amidei, Claudio Barbiellini and Antonelli, Giulio and Germanà, Bastianello and Valiante, Flavio and Benvenuti, Stefano and Tringali, Alberto and Bortoluzzi, Francesco and Cervellin, Erica and Giacomin, Davide and Meggiato, Tamara and Rizzotto, Erik Rosa and Fregonese, Diego and Dinca, Manuela and Baldassarre, Gianluca and Scalon, Paola and Pantalena, Maurizio and Milan, Luisa and Bulighin, Gianmarco and Di Piramo, Daniele and Azzurro, Maurizio and Gabbrielli, Armando and Repici, Alessandro and Rugge, Massimo and Veneto Screening Endoscopists Working Group, Veneto Screening Endoscopists Working Group and Hassan, Cesare},
title = {Low Colorectal Cancer Risk After Resection of High-Risk Pedunculated Polyps},
journal = {Clinical Gastroenterology and Hepatology},
year = {2024},
doi = {10.1016/j.cgh.2024.01.027}
}
EUVIMED